Post on 11-Jan-2016
UNITAID’s Market Approach inHIV Diagnostics
Brenda Waning
International AIDS Society 18 July, 2011
Rome
Presentation Outline
• Overview of UNITAID
• Description of UNITAID’s market approach to improve public health
• Summary of UNITAID’s current and planned activities in the area of HIV diagnostics
UNITAID: a WHO Partnership moving markets
PartnersWorking towards the common goal of
expanding access to health
• Est. 2006: Innovative finance mechanism based largely on air tax levies from north & south
• Geneva-based secretariat: no in-country offices – work with partners
• Work exclusively through markets to improve access to medicines, diagnostics and preventative items for HIV/AIDS, tuberculosis, and malaria
UNITAID Goal
UNITAID aims to promote “healthy”, dynamic market conditions whereby manufacturers have incentives to invest and innovate, while at the same time supply quality public health products at sustainable, affordable prices and in acceptable formulations that enable the maximum number of people to access them.
How UNITAID intervenes UNITAID’s role depends upon the particular circumstances in a given market:
• Market catalyst: identifying and facilitating adoption and uptake of new and/or superior public health products;
• Market creator: providing incentives for manufacturers to produce otherwise unattractive products with low demand that yield little profit but substantial public health benefit to those in need; and
• Market “fixer”: addressing severe market inefficiencies (e.g. grossly inaccurate demand forecasts and excessive transaction costs) that contribute to low access to quality-assured public health products.
UNITAID Market impact framework
Pathway from market to public health impactCase for intervention
Public health problem & commodity
access issues
Market shortcoming
and their reasons
Innovative market
intervention
Sustainable market impact
Public health impact
UNITAID Market impact framework
UNITAID Intervention example: 2nd line ARV market
Pathway from market to public health impactCase for intervention
HIV/AIDS & poor access
to anitretroviral
(ARV) medicines
High ARV prices from low demand
& lack of competition
Price negotiation,
demand creation, pooled
purchase, information
sharing, WHO PQ
Lower ARV prices, more
generic versions,
increase in suppliers,
competition & awareness
More people treated with less money;
benefits extend beyond country
recipients
Partners: Clinton Health Access Initiative (CHAI), WHO Prequalification Programme for Medicines
UNITAID current & planned activities in HIV diagnostics (1))
• Landscape analyses• map the landscape (disease, technology, market) for
diagnostics across the 3 diseases• update every 6 months• internal value - inform priorities, decision making• external value: public good to other organizations
• Call for letters of intent (and then proposals) for projects to increase access to diagnostics in the 3 disease areas• expected launch: last week of July 2011• To be posted on website: www.unitaid.eu
HIV Diagnostics LandscapeReleased 1 June
UNITAID current & planned activities in HIV diagnostics (2)
• Create mechanisms to compare potential projects against UNITAID prioritization criteria:• Market impact• Public health impact• Innovation• Value for money
• Provide all inputs (landscapes, prioritization analyses) to UNITAID technical & decision-making bodies
• Continue dialogue with other organizations• this session: dissemination & feedback
Thank you
Contact Information:
Brenda Waning
Coordinator, Market Dynamics
UNITAID
Email: waningb@who.int